Abbott Laboratories logo

Abbott Laboratories

NEW
NYSE:ABT (USA)  
$ 99.67 -1.99 (-1.96%) 03:59 PM EST
32.26
P/B:
3.33
Market Cap:
$ 173.61B
Enterprise V:
$ 201.00B
Volume:
7.53M
Avg Vol (2M):
13.68M
Trade In:
Volume:
7.53M
Avg Vol (2M):
13.68M
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PS Ratio for ABT ( Abbott Laboratories ) from 1990 to Jul 21 2026. The price to sales ratio is calculated by taking the current stock price and dividing it by the trailing twelve-month sales per share. The data is updated every 20 minutes during market hours. The PS ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS ratio is a great valuation tool for evaluating cyclical businesses where the PE ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean. Abbott Laboratories stock (ABT) PS ratio as of Jul 21 2026 is 3.77. More Details

Abbott Laboratories (ABT) PS Ratio Chart

To

Abbott Laboratories (ABT) PS Ratio Historical Data

Total 1207
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Abbott Laboratories PS Ratio Historical Data
Date PS Ratio Data Date PS Ratio Data
2026-07-21 3.8 3.82 3.72 3.73 2026-05-14 3.3 3.3 3.26 3.29
2026-07-20 3.8 3.84 3.75 3.81 2026-05-13 3.2 3.26 3.2 3.25
2026-07-17 3.8 3.83 3.73 3.77 2026-05-12 3.2 3.3 3.22 3.27
2026-07-16 3.6 3.82 3.56 3.7 2026-05-11 3.3 3.27 3.17 3.2
2026-07-15 3.3 3.37 3.28 3.34 2026-05-08 3.4 3.38 3.26 3.27
2026-07-14 3.4 3.39 3.32 3.33 2026-05-07 3.3 3.42 3.34 3.37
2026-07-13 3.5 3.53 3.43 3.45 2026-05-06 3.4 3.4 3.34 3.34
2026-07-10 3.6 3.56 3.5 3.52 2026-05-05 3.4 3.4 3.34 3.38
2026-07-09 3.5 3.56 3.52 3.54 2026-05-04 3.5 3.47 3.38 3.39
2026-07-08 3.6 3.6 3.53 3.57 2026-05-01 3.5 3.52 3.45 3.46
2026-07-07 3.6 3.68 3.59 3.59 2026-04-30 3.5 3.54 3.5 3.52
2026-07-06 3.6 3.59 3.48 3.58 2026-04-29 3.6 3.63 3.54 3.54
2026-07-02 3.5 3.59 3.44 3.57 2026-04-28 3.6 3.67 3.61 3.64
2026-07-01 3.5 3.52 3.44 3.45 2026-04-27 3.5 3.61 3.52 3.59
2026-06-30 3.5 3.5 3.39 3.4 2026-04-24 3.6 3.59 3.53 3.53
2026-06-29 3.5 3.56 3.47 3.47 2026-04-23 3.5 3.58 3.51 3.58
2026-06-26 3.6 3.69 3.61 3.65 2026-04-22 3.6 3.64 3.55 3.55
2026-06-25 3.5 3.66 3.5 3.61 2026-04-21 3.7 3.71 3.59 3.59
2026-06-24 3.5 3.6 3.5 3.5 2026-04-20 3.7 3.77 3.7 3.72
2026-06-23 3.5 3.52 3.44 3.51 2026-04-17 3.7 3.76 3.67 3.75
2026-06-22 3.4 3.43 3.38 3.4 2026-04-16 3.8 3.83 3.64 3.7
2026-06-18 3.4 3.46 3.4 3.42 2026-04-15 3.9 3.97 3.9 3.93
2026-06-17 3.5 3.55 3.4 3.43 2026-04-14 3.9 3.96 3.89 3.91
2026-06-16 3.5 3.51 3.44 3.51 2026-04-13 3.9 3.91 3.84 3.9
2026-06-15 3.4 3.45 3.4 3.43 2026-04-10 4.0 3.98 3.85 3.88
2026-06-12 3.5 3.5 3.37 3.42 2026-04-09 4.0 4 3.95 3.98
2026-06-11 3.5 3.5 3.44 3.47 2026-04-08 4.0 4.02 3.92 4.01
2026-06-10 3.5 3.54 3.43 3.45 2026-04-07 3.9 3.98 3.93 3.94
2026-06-09 3.5 3.56 3.49 3.53 2026-04-06 4.0 3.99 3.94 3.96
2026-06-08 3.5 3.54 3.49 3.51 2026-04-02 4.0 4.01 3.93 3.98
2026-06-05 3.5 3.59 3.52 3.53 2026-04-01 4.0 4.02 3.96 3.97
2026-06-04 3.5 3.54 3.45 3.52 2026-03-31 4.0 4.02 3.91 3.98
2026-06-03 3.4 3.41 3.36 3.37 2026-03-30 4.1 4.06 3.94 3.95
2026-06-02 3.4 3.4 3.33 3.37 2026-03-27 4.1 4.16 4.09 4.1
2026-06-01 3.3 3.41 3.32 3.4 2026-03-26 4.1 4.18 4.1 4.12
2026-05-29 3.4 3.36 3.3 3.32 2026-03-25 4.2 4.17 4.11 4.13
2026-05-28 3.3 3.35 3.3 3.34 2026-03-24 4.1 4.11 4.04 4.1
2026-05-27 3.4 3.36 3.29 3.32 2026-03-23 4.2 4.22 4.1 4.13
2026-05-26 3.4 3.37 3.32 3.36 2026-03-20 4.2 4.25 4.16 4.16
2026-05-22 3.4 3.44 3.37 3.39 2026-03-19 4.3 4.33 4.22 4.23
2026-05-21 3.4 3.43 3.36 3.4 2026-03-18 4.3 4.34 4.25 4.28
2026-05-20 3.4 3.44 3.37 3.42 2026-03-17 4.3 4.41 4.33 4.37
2026-05-19 3.4 3.46 3.39 3.44 2026-03-16 4.3 4.34 4.28 4.34
2026-05-18 3.3 3.41 3.27 3.4 2026-03-13 4.3 4.35 4.25 4.26
2026-05-15 3.3 3.35 3.26 3.27 2026-03-12 4.3 4.38 4.26 4.26

Abbott Laboratories (ABT) PS Ratio Comparison

Company Market Cap(Mil) PS Ratio

Business Description

Business Description

Description
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.